ilomastat has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 1 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Trials (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 792 | 16 | 476 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hur, MA; Laforest, R; Lapi, SE; Mebrahtu, E; Zheleznyak, A | 1 |
1 other study(ies) available for ilomastat and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
Initial characterization of a dually radiolabeled peptide for simultaneous monitoring of protein targets and enzymatic activity.
Topics: Amino Acid Sequence; Cell Line, Tumor; Copper Radioisotopes; Drug Stability; Enzyme Assays; Heterocyclic Compounds, 1-Ring; Humans; Hydroxamic Acids; Indoles; Integrin alphaVbeta3; Iodine Radioisotopes; Isotope Labeling; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Multimodal Imaging; Oligopeptides; Phantoms, Imaging; Positron-Emission Tomography; Proteolysis; Time Factors; Tomography, X-Ray Computed | 2013 |